Kevin C. Knightly, President, IMS EMEA at IMS HEALTH INC (RX), sold 139,620 shares at $29.67 ($4.1M) on 2007-02-20, disclosed to the SEC on 2007-02-22.
Open-market sale of $4.1M RX by President, IMS EMEA. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.55 | 4,700 | $139K | 3.4% |
| 2 | $29.56 | 4,200 | $124K | 3.0% |
| 3 | $29.57 | 13,100 | $387K | 9.4% |
| 4 | $29.58 | 12,900 | $382K | 9.2% |
| 5 | $29.59 | 4,200 | $124K | 3.0% |
| 6 | $29.60 | 13,900 |
| $411K |
| 10.0% |
| 7 | $29.61 | 32,200 | $953K | 23.1% |
| 8 | $29.62 | 13,220 | $392K | 9.5% |
| 9 | $29.63 | 5,900 | $175K | 4.2% |
| 10 | $29.64 | 9,800 | $290K | 7.0% |
| 11 | $29.65 | 16,400 | $486K | 11.8% |
| 12 | $29.66 | 1,700 | $50K | 1.2% |
| 13 | $29.67 | 7,400 | $220K | 5.3% |
| Total | $29.61 avg | 139,620 | $4.1M | 100% |
| Filing → |
| IQV | SELL | 2023-12-05 | $5.6M | — | Filing → |
| IQV | SELL | 2023-06-07 | $2.3M | — | Filing → |
| IQV | SELL | 2023-05-31 | $199 | — | Filing → |